Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing

Nikolajs Zeps, Tamra Lysaght, Ruth Chadwick, Alexandre Erler, Roger Foo, Simona Giordano, Poh San Lai, G. Owen Schaefer, Vicki Xafis, Wei Leong Chew,

Stem Cell Reports · 2021 · 21 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

Altering the human epigenome with gene-editing technology in attempt to treat a variety of diseases and conditions seems scientifically feasible. We explore some of the ethical and regulatory issues related to the clinical translation of human epigenetic editing arguing that such approaches should be considered akin to somatic therapies. Altering the human epigenome with gene-editing technology in attempt to treat a variety of diseases and conditions seems scientifically feasible. We explore some of the ethical and regulatory issues related to the clinical translation of human epigenetic editing arguing that such approaches should be considered akin to somatic therapies.

References

5